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The purpose of this work was to supervise the activity and health of the mammary gland in dairy 
cows in a dairy specialty unit in Cluj County. The objectives of this study can be summarized as follows: 
diagnosis of mastitis, carrying out a study on the incidence of mastitis according to some factors, performing 
the microbiological exam and treatment. Following the clinical examination, 6 cows (5.36%) were diagnosed 
with clinical mastitis. Depending on the type of lesion, it was found that acute mastitis had the highest rate 
(66.66%), and according to the symptomatology, there were found 2 cases (33.33%) with haemorrhagic 
mastitis, catarrhal mastitis and purulent mastitis. The highest incidence of clinical mastitis based on the 
number of lactations was in cows at 3th and 4th lactation (83.33%). Depending on age, all cases of clinical 
mastitis have been detected in cows aged 4-7 years. After the application of the Kerba Test method, a total 
of 10 cows (8.93%) were diagnosed with subclinical mastitis. The incidence of subclinical mastitis according 
to the age of the animals shows that 60% of the cases were recorded in cows aged 5-7 years. The incidence 
of subclinical mastitis regarding the number of lactations was 20% in cows at 5th lactation, 10% in those at 
4th lactation, 30% in those at the 3th lactation, 30% in the 2nd lactation and 10% in the first lactation cows. 
Bacteriological exam revealed that the most commonly encountered pathogen was Staphylococcus spp. As 
regards the treatment of clinical mastitis, comparing the average of administrations, we observed a better 
efficacy of Masti Veyxym and Synulox LC therapy than in the treatment that used exclusively Synulox LC 
(2.5 vs. 4.5), although performed under the same conditions. In subclinical mastitis we achieved 100% 
healing after a single administration. 
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Introduction 
Mastitis is defined as an inflammation of the parenchyma of mammary gland, which can 
reduce milk yield and alter milk composition (Souto et al., 2010). There are two main classes of 
mastitis. The first is clinical mastitis, which manifests signs observed from the animal or the milk. 
The other is subclinical mastitis, which produces no visible signs from the udder except when using 
diagnostic tools. The reduction in milk production attributed to sub-clinical mastitis may account 
for 70%–80% of the total losses (Philpot and Nickerson, 1991). 
Mastitis control program can reduce economical loss and increase herd efficacy and milk 
hygiene. Epidemiological data including mastitis prevalence, mastitis causing organisms, 
predisposing factors and response to treatment, are necessary for the establishment of a mastitis 
control program (Hashemi et al., 2011). 
The purpose of this work was to supervise the activity and health of the mammary gland 
in dairy cows in a dairy specialty unit in Cluj County. The objectives of this study can be 
summarized as follows: diagnosis of mastitis, carrying out a study on the incidence of mastitis 
according to some factors, performing the microbiological exam and treatment of the mastitis 
 
Materials and method 
The study was performed in a private dairy farm located in Cluj County, between 





Diagnosis of clinical mastitis. The diagnosis of clinical mastitis was based on the clinical 
examination, which consisted on inspection and palpation of the udder and milking test. 
Diagnosis of subclinical mastitis. Subclinical mastitis detection was performed using the 
Kerba Test method. 
Bacteriological examination of milk samples collected from cows suffering from bovine 
mastitis. For the isolation of microorganisms from mastitis milk samples, common culture media 
were used: broth, glucose agar 1‰, sheep blood agar 5%, selective media (Baird-Parker medium), 
and MacConkey gel for Enterobacteriaceae. The protocol has the following stages: collecting milk 
samples, preparation of samples, seeding samples and performing antibiogram method – diffusion 
technique. Standardized micro-tablets were used with the following antibacterial agents: 
amoxiclav, ceftiofur, mastidisc, enrofloxacin, florfenicol, penicillin, gentamycin, cloxacillin and 
colistin. 
Treatment of mastitis. Treatment of clinical mastitis was performed with two products, 
depending on the type of disease: Nekro Veyxym, solution for injection and Synulox LC., 
intramammary suspension. For the treatment of subclinical mastitis the Tetra-Delta intramammary 
product was used. 
 
Results and discussions 
After the clinical examination, 6 cows (5.36%) were diagnosed with clinical mastitis (CM) 
and by the Kerba Test method, 10 cows (8.93%) were diagnosed with subclinical mastitis (SBM). 
In the present study, like some other studies, the majority of the cases of mastitis were subclinical 
(Almaw et al., 2008; Getahun et al., 2008; Hashemi et al., 2011). 
After the organoleptic examination of the milk were identified 3 cases (50%) with catarrhal 
mastitis, 1 case (16.66%) with haemorrhagic mastitis and 2 cases (33.33%) with purulent mastitis. 
Analyzing the frequency of mastitis in cows, in relation to age, the highest value for subclinical 
mastitis was observed in cows ranging between 4-7 years - 60% and for clinical mastitis was 
66.66% in cows aged beetwen 6-7 years. The occurrence of the mastitis is directly proportional to 
the number of lactations. For clinical mastitis, the maximum incidence was found during the fourth 
lactation (66.66%), while the minimum value was recorded during the second and third lactation 
(16.66%). The same report was maintained for subclinical mastitis with limits between 10% (first 
lactation) and 40% (fourth lactation). The highest incidence of subclinical mastitis depending on 
the affected quarter was recorded for the hindquarters (clinical mastitis – 83.33%, subclinical 
mastitis B - 80%). 
Our investigations were conducted on a number of 10 milk samples selectively collected 
from cows diagnosed with clinical and subclinical mastitis. Samples were collected from a single 
quarter, usually the affected or all quarters when the entire mammary gland was affected. 
Bacteriological examination led to the isolation of microorganisms belonging to 5 different types: 
Staphylococcus, Micrococcus, Bacillus, Escherichia, and Trueperella. Staphylococcus spp. was 
isolated from 8 samples (80%), alone or in association with other species (Escherichia coli, 
Bacillus). Staphylococcus was isolated in pure culture from 4 samples (40%). Staphylococcus 
associated with Escherichia coli or Bacillus was isolated from 4 samples (40%) each. In 10% of 
the samples, were identified Micrococus alone or associated with Trueperella pyogenes. The 
results regarding the study of the sensitivity of isolated strains to various antibacterial substances 
are systematized in Table 1. 
Staphylococci were the predominant bacteria as the cause of mastitis, which is in 
agreement with the findings of Meranzadeh et al. (2001) and Gharagozloo et al. (2003) 
Treatment of haemorrhagic mastitis was performed with Synulox LC for 3-4 days, single 





repeated milking was not performed (only in the morning and in the evening). Regarding catarrhal 
and purulent mammals, the therapeutic protocol was carried out with two products: Nekro Veyxym 
and Synulox LC. The first product was administered once/day (in the evening), 0.4 ml/10 kg, 
intramuscularly, while the second product was administered 2 times/day, intramammary (morning 
and evening). A number of 5 cows (83.33%) were fully recovered after 2-4 days of treatment. A 
single cow (16.66%) with purulent mastitis was partially recovered, the affected quarters 
presenting clinical healing but with the reduction of glandular tissue in favor of connective tissue, 
the sclerosis of the quarter and reduced productivity. Comparing the average of administrations, 
we observed a better efficacy of Masti Veyxym and Synulox LC therapy than in the treatment that 
used exclusively Synulox LC (2.5 vs. 4.5), although performed under the same conditions. 
In subclinical mastitis we achieved 100% healing after a single administration of Tetra 
Delta product. 
 




of the sample 
Staphylococcus 
AMC EFT NBT ENF5 FL30 P10 G10 CLOXA CS 
(CX30) 
spp. /530 R 15,01 26,10 26,21 22,43 10,80 18,66 28,14 R 
 Staphylococcus R 16,14 24,46 19,89 22,98 15,87 19,19 22,47 10,41 
spp. /531 
 Staphylococcus R 14,02 25,59 25,74 19,67 R 17,40 19,18 R 
spp. /533 
 
Staphylococcus R 10,90 23,58 25,01 18,98 R 16,53 19,55 R 
spp. /534 
Bacil 13,52 19,51 22,70 23,44 25,82 24,79 20,34 20,64 13,16 
nehemolitic/534 
 Staphylococcus R 12,06 22,41 22,45 21,64 R 16,25 19,55 R 
spp. /536 
 Staphylococcus R 14,64 22,18 18,75 22,59 15,28 19,79 19,22 R 
spp. /537 









25,84 34,80 32,04 30,30 36,26 27,60 23,92 R 
 
Sensitivity 20% 90% 100% 100% 100% 60% 100% 100% 20% 
 
AMC30: amoxicilin + clavulanic acid; EFT: ceftiofur; NBT 70: mastidisc (neomicin 





1. Sixteen cows (14.29%) were diagnosed as positive with subclinical and clinical mammitis; 
2. Following the clinical examination a number of 6 cows (5.36%) were diagnosed with 
clinical mastitis, and by the Kerba Test method, a number of 10 cows (8.93%) with 
subclinical mastitis; 
3. The most common pathogen was Staphylococcus spp .; 
4. As regards the treatment of clinical mastitis, comparing the average of administrations, we 





that used exclusively Synulox LC (2.5 vs. 4.5), although performed under the same 
conditions. 
5. In subclinical mastitis we achieved 100% healing after a single administration. 
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